Tiziana Life Sciences (LON:TILS) Share Price Passes Above 50-Day Moving Average – Should You Sell?

Tiziana Life Sciences PLC (LON:TILS) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 58.50 ($0.74) and traded as high as GBX 59 ($0.74). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.74), with a volume of 297,127 shares.

Tiziana Life Sciences Price Performance

The company has a market capitalization of £113.85 million and a PE ratio of -3.59. The company has a quick ratio of 6.41, a current ratio of 6.54 and a debt-to-equity ratio of 2.36. The company’s 50 day moving average is GBX 58.50 and its two-hundred day moving average is GBX 58.50.

About Tiziana Life Sciences

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.